This report was recently updated on April 18 2024 with the latest and most recent
market numbers
Global Cell & Gene Therapy Raw Material Testing Market Size, Trends & Analysis - Forecasts to 2027 By Type Scope (Cell Therapy, Gene Therapy), By Service Scope (Sterility Testing, Mycoplasma Detection Assays, Endotoxin Detection, Bioburden Testing, Others), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis
The Global Cell & Gene Therapy Raw Material Testing Market is projected to grow from USD 13.1 billion in 2022 to USD 21.3 billion in 2027 at a CAGR of 17.3% from 2022 to 2027.
The cell and gene therapy raw material testing market is estimated to exhibit substantial growth during the forecast period due to several factors such as expansion in clinical research, government funding, and initiatives targeted toward cell therapy research and efficiency in the treatment over the years. Raw materials used in processing cells have different characteristics which help in the development and growth of cells.
Cell & gene therapy is extremely crucial for life-threatening diseases such as cancer, leukemia, and cardiovascular diseases. Furthermore, it is required for advanced therapy medical products (ATMPs) where medical treatments are based on genes and tissues. These tissue-engineered medicines can be modified as per the patient’s requirement which also helps in replacing dead cells. The European Commission in 2017 aimed to streamline procedures and give better research facilities for ATMP treatments.
Cell and gene therapy equipment and consumables are expensive but due to their wide application in clinical research as well as in treating diseases, the global cell & gene therapy raw material testing market is estimated to increase during the forecast period.
The COVID-19 pandemic did have a significant impact on the global cell & gene therapy raw material testing market. Cell and gene therapy technology was implemented in vaccine trials and the production of drugs and medications for COVID-19. Cell and gene therapy was used for the formulation and harvesting of cells for CAR-T cell therapies and it had a significant growth rate in the global cell & gene therapy raw material testing market.
The pandemic did affect supply chain management due to lockdowns and restrictions. Furthermore, there was a delay in elective procedures and surgeries for cancer treatments as well as other complex diseases and this affected the patients in rural areas. Inadequate workforce and diversion of healthcare workers for covid-19 affected the research aimed at cell therapy and cancer management. However, with ease in restrictions post-pandemic, many institutions have issued separate guidelines for the oncology department and its treatment facilities, and thus it is expected to function properly.
The war between Russia and Ukraine had a substantial impact on the global cell & gene therapy raw material testing market. Russia is one of the major suppliers of healthcare and medical devices and due to the rise in transportation costs and low production due to war, the market in Russia has been affected majorly. These disruptions also affect the neighboring regions in Europe. Countries are facing disruptions in the ongoing clinical trials.
Europe is among one the countries with significant research institutes and other healthcare facilities. This impacts the political relations in the international market. Ukraine imports many technologies and devices for chronic diseases and due to uncertainty in the market, they are facing production delays. With companies shutting their plants temporarily and all the above-mentioned reasons, the markets in Russia and Ukraine are facing supply shortages.
The cell therapy segment is expected to witness the largest share in the global cell & gene therapy raw material testing market during the forecast period of 2022-2027. Cell therapy can help consumers with cardiovascular diseases by helping the blood vessels and numerous cell functioning factors. The healthy tissue also helps in the regeneration of collagen and stimulates healthy skin and hair. The recovery rate after cell therapy is much faster and this drives the market during the forecast period.
The gene therapy segment is expected to grow the fastest during 2022-2027. Gene therapy helps cure genetic disorders and patients developing cancer. Due to ongoing technological advancements, it also has a long-lasting effect and this can help in managing the disease by improving the quality of life. For instance, since the FDA approval for gene therapy, Pfizer is introducing vector designs and developing labs for gene mutation and therapy, and growing the research at a significant rate.
The sterility testing segment is expected to witness the largest share in the global cell & gene therapy raw material testing market during the forecast period of 2022-2027. Sterility testing identifies the expected probability of the materials included in the gene and cell therapy formation. Sterilizing also predicts the survival rate of the cells before inserting them into a patient’s body. Furthermore, sterility testing filters contaminated microorganisms and this drives the market during the forecast period.
The endotoxin detection segment is expected to grow the fastest during 2022-2027. Cell therapies have promising results for cancer patients as well as for other chronic diseases. The endotoxin detection segment is required for testing gram-negative bacteria which have serious effects on patients. CAR-T cells are tested for accurate parameters.
The North American segment is expected to witness the largest share in the global cell & gene therapy raw material testing market during the forecast period of 2022-2027. Due to an increase in research in the healthcare segment, the North American segment will dominate the global cell & gene therapy raw material testing market.
An increase in the standard of living, and new technologies in the medical sector are a few reasons which drive the market in the United States. As one of the most developed nations in the world, the United States is a hub for complex medical treatments for many people around the world. For instance, a research institute in the United States is home to a massive number of transplant recipients for allogeneic transplantation. The cell & gene therapy raw material testing market industry in the United States has been substantially strong because of better infrastructure facilities and a wide range of treatments.
Asia-Pacific is expected to grow the fastest during 2022-2027. The Asia-Pacific region has been developing a huge infrastructure for the healthcare sector and many medical advancements via research. Furthermore, it has been rising technology and other advancements in the field of technical innovation. This boosts the global cell & gene therapy raw material testing market.
The markets in Southeast Asia, Korea, and India are also expanding their businesses and contributing to the global economy significantly. China is leading in the gene therapy development market with advanced trials and clinical research. As per a KPMG report, China also holds the second position for CAR-T clinical trials. The first CAR-T testing was available in 2019 in Japan due to revised clinical guidelines. On the other hand, India has contributed significantly to the process of vaccines during the pandemic. Hence, considering these advantages the global cell & gene therapy raw material testing market is expected to grow.
There is also substantial growth due to investments in research and development especially in stem cell research due to the increase in chronic diseases. This competitive landscape helps in the growth rate of the global cell & gene therapy raw material testing market. Furthermore, due to collaborative research projects, renowned companies are expanding their business in Europe for cell therapy as well as treatments for pre-cancer indications
Thermo Fisher Scientific, Merck KGaA, Catalent Inc., Charles River, Pace Analytical Life Sciences, Agilent Technologies, Intertek Group PLC, Element Material Technology, and Eurofins Scientific, among others, are some key players in the cell & gene therapy raw material testing market.
Please note: This is not an exhaustive list of companies profiled in the report.
The global cell & gene therapy raw material testing market has observed several strategic alliances between company profiles to launch new products with added functionalities and maintain revenue share & profitability. Organic and inorganic growth strategies adopted by small players have been the highlight of this market.
Chapter 1 Research Methodology
1.1 Research Assumptions
1.2 Research Methodology
1.2.1 Estimates and Forecast Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GME’s Internal Database
1.3.3 Primary Research
1.3.4 Secondary Sources & Third-Party Perspectives
1.3.4.1 Company Information Sources
1.3.4.2 Secondary Data Sources
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Data Visualization
1.6 Data Validation & Publishing
1.7 Market Model
1.7.1 Model Details
1.7.1.1 Top-Down Approach
1.7.1.2 Bottom-Up Approach
1.8 Market Segmentation & Scope
1.9 Market Definition
Chapter 2 Executive Summary
2.1 Global Market Outlook
2.2 Type Scope Outlook
2.3 Service Scope Outlook
2.4 Regional Outlook
Chapter 3 Global Cell & Gene Therapy Raw Material Testing Market Trend Analysis
3.1. Market Introduction
3.2 Penetration & Growth Prospect Mapping
3.3 Impact of COVID-19 on the Cell & Gene Therapy Raw Material Testing Market
3.4 Metric Data based on the industry
3.5 Market Dynamic Analysis
3.5.1 Market Driver Analysis
3.5.2 Market Restraint Analysis
3.5.3 Industry Challenges
3.5.4 Industry Opportunities
3.6 Porter’s Five Analysis
3.6.1 Supplier Power
3.6.2 Buyer Power
3.6.3 Substitution Threat
3.6.4 Threat from New Entrant
3.7 Market Entry Strategies
Chapter 4 Cell & Gene Therapy Raw Material Testing Market: By Service Scope Trend Analysis
4.1 By Service Scope: Historic Data vs. Forecast Data Analysis, 2021 vs. 2027
4.2 Sterility Testing
4.2.1 Market Estimates & Forecast Analysis of Sterility Testing, By Region, 2019-2027 (USD Billion)
4.3 Mycoplasma Detection Assays
4.3.1 Market Estimates & Forecast Analysis of Mycoplasma Detection Assays Market Segment, By Region, 2019-2027 (USD Billion)
4.4 Endotoxin Detection
4.4.1 Market Estimates & Forecast Analysis of Endotoxin Detection Segment, By Region, 2019-2027 (USD Billion)
4.5 Bioburden Testing
4.5.1 Market Estimates & Forecast Analysis of Bioburden Testing Market Segment, By Region, 2019-2027 (USD Billion)
4.6 Others
4.6.1 Market Estimates & Forecast Analysis of Others Market Segment, By Region, 2019-2027 (USD Billion)
Chapter 5 Cell & Gene Therapy Raw Material Testing Market: By Type Scope Trend Analysis
5.1 By Type Scope: Historic Data vs. Forecast Data Analysis, 2022 vs. 2027
5.2 Cell Therapy
5.2.1 Market Estimates & Forecast Analysis of Cell Therapy Segment, By Region, 2019-2027 (USD Billion)
5.3 Gene Therapy
5.3.1 Market Estimates & Forecast Analysis of Gene Therapy Segment, By Region, 2019-2027 (USD Billion)
Chapter 6 Cell & Gene Therapy Raw Material Testing Market, By Region
6.1 Regional Outlook
6.2 North America
6.2.1 Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Billion)
6.2.2 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.2.3 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.2.4 U.S.
6.2.4.1 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.2.4.2 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.2.5 Canada
6.2.5.1 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.2.5.2 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.2.6 Mexico
6.2.6.1 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.2.6.2 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.3 Europe
6.3.1 Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Billion)
6.3.2 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.3.3 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.3.4 Germany
6.3.4.1 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.3.4.2 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.3.5 UK
6.3.5.1 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.3.5.2 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.3.6 France
6.3.6.1 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.3.6.2 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.3.7 Russia
6.3.7.1 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.3.7.2 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.3.8 Italy
6.3.8.1 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.3.8.2 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.3.9 Spain
6.3.9.1 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.3.9.2 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.3.10 Rest of Europe
6.3.10.1 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.3.10.2 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.4 Asia Pacific
6.4.1 Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Billion)
6.4.2 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.4.3 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.4.4 China
6.4.4.1 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.4.4.2 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.4.5 India
6.4.5.1 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.4.5.2 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.4.6 Japan
6.4.6.1 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.4.6.2 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.4.7 Australia
6.4.7.1 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.4.7.2 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.4.8 South Korea
6.4.8.1 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.4.8.2 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.3.9 Rest of Asia Pacific
6.3.9.1 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.3.9.2 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.5 Central & South America
6.5.1 Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Billion)
6.5.2 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.5.3 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.5.4 Brazil
6.5.4.1 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.5.4.2 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.5.5 Rest of Central & South America
6.5.5.1 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.5.5.2 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.6 Middle East & Africa
6.6.1 Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Billion)
6.6.2 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.6.3 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.6.4 Saudi Arabia
6.6.4.1 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.6.4.2 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.6.5 United Arab Emirates
6.6.5.1 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.6.5.2 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.6.6 South Africa
6.6.6.1 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.6.6.2 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
6.6.7 Rest of Middle East & Africa
6.6.7.1 Market Estimates & Forecast Analysis, By Service Scope, 2019-2027 (USD Billion)
6.6.7.2 Market Estimates & Forecast Analysis, By Type Scope, 2019-2027 (USD Billion)
Chapter 7 Competitive Analysis
7.1 Key Global Players, Recent Developments & their Impact on the Industry
7.2 Four Quadrant Competitor Positioning Matrix
7.2.1 Key Innovators
7.2.2 Market Leaders
7.2.3 Emerging Players
7.2.4 Market Challengers
7.3 Vendor Landscape Analysis
7.4 End-User Landscape Analysis
7.5 Company Market Share Analysis, 2021
Chapter 8 Company Profile Analysis
8.1 Thermo Fisher Scientific
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Strategic Initiatives
8.1.4 Product Benchmarking
8.2 Merck KGaA
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Strategic Initiatives
8.2.4 Product Benchmarking
8.3 Catalent Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Strategic Initiatives
8.3.4 Product Benchmarking
8.4 Charles River
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Strategic Initiatives
8.4.4 Product Benchmarking
8.5 Pace Analytical Life Sciences
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Strategic Initiatives
8.5.4 Product Benchmarking
8.6 Agilent Technologies
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Strategic Initiatives
8.6.4 Product Benchmarking
8.7 Intertek Group
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Strategic Initiatives
8.7.4 Product Benchmarking
8.8 Element Material Technology
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Strategic Initiatives
8.8.4 Product Benchmarking
8.9 Eurofins Scientific
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Strategic Initiatives
8.9.4 Product Benchmarking
8.10 Other Companies
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Strategic Initiatives
8.10.4 Product Benchmarking
List of Tables
1 Technological Advancements in Cell & Gene Therapy Raw Material Testing Market
2 Global Cell & Gene Therapy Raw Material Testing Market: Key Market Drivers
3 Global Cell & Gene Therapy Raw Material Testing Market: Key Market Challenges
4 Global Cell & Gene Therapy Raw Material Testing Market: Key Market Opportunities
5 Global Cell & Gene Therapy Raw Material Testing Market: Key Market Restraints
6 Global Cell & Gene Therapy Raw Material Testing Market Estimates & Forecast Analysis, 2019-2027 (USD Billion)
7 Global Cell & Gene Therapy Raw Material Testing Market, By Service Scope, 2019-2027 (USD Billion)
8 Sterility Testing: Global Cell & Gene Therapy Raw Material Testing Market, By Region, 2019-2027 (USD Billion)
9 Endotoxin Detection: Global Cell & Gene Therapy Raw Material Testing Market, By Region, 2019-2027 (USD Billion)
10 Mycoplasma Detection Assays: Global Cell & Gene Therapy Raw Material Testing Market, By Region, 2019-2027 (USD Billion)
11 Bioburden Testing: Global Cell & Gene Therapy Raw Material Testing Market, By Region, 2019-2027 (USD Billion)
12 Others: Global Cell & Gene Therapy Raw Material Testing Market, By Region, 2019-2027 (USD Billion)
13 Global Cell & Gene Therapy Raw Material Testing Market, By Type Scope, 2019-2027 (USD Billion)
14 Cell Therapy: Global Cell & Gene Therapy Raw Material Testing Market, By Region, 2019-2027 (USD Billion)
15 Gene Therapy: Global Cell & Gene Therapy Raw Material Testing Market, By Region, 2019-2027 (USD Billion)
16 Regional Analysis: Global Cell & Gene Therapy Raw Material Testing Market, By Region, 2019-2027 (USD Billion)
17 North America: Cell & Gene Therapy Raw Material Testing Market, By Service Scope, 2019-2027 (USD Billion)
18 North America: Cell & Gene Therapy Raw Material Testing Market, By Type Scope, 2019-2027 (USD Billion)
19 North America: Cell & Gene Therapy Raw Material Testing Market, By Country, 2019-2027 (USD Billion)
20 U.S: Cell & Gene Therapy Raw Material Testing Market, By Service Scope, 2019-2027 (USD Billion)
21 U.S: Cell & Gene Therapy Raw Material Testing Market, By Type Scope, 2019-2027 (USD Billion)
22 Canada: Cell & Gene Therapy Raw Material Testing Market, By Service Scope, 2019-2027 (USD Billion)
23 Canada: Cell & Gene Therapy Raw Material Testing Market, By Type Scope, 2019-2027 (USD Billion)
24 Mexico: Cell & Gene Therapy Raw Material Testing Market, By Service Scope, 2019-2027 (USD Billion)
25 Mexico: Cell & Gene Therapy Raw Material Testing Market, By Type Scope, 2019-2027 (USD Billion)
26 Europe: Cell & Gene Therapy Raw Material Testing Market, By Service Scope, 2019-2027 (USD Billion)
27 Europe: Cell & Gene Therapy Raw Material Testing Market, By Type Scope, 2019-2027 (USD Billion)
28 Europe: Cell & Gene Therapy Raw Material Testing Market, By Country, 2019-2027 (USD Billion)
29 Germany: Cell & Gene Therapy Raw Material Testing Market, By Service Scope, 2019-2027 (USD Billion)
30 Germany: Cell & Gene Therapy Raw Material Testing Market, By Type Scope, 2019-2027 (USD Billion)
31 UK: Cell & Gene Therapy Raw Material Testing Market, By Service Scope, 2019-2027 (USD Billion)
32 UK: Cell & Gene Therapy Raw Material Testing Market, By Type Scope, 2019-2027 (USD Billion)
33 France: Cell & Gene Therapy Raw Material Testing Market, By Service Scope, 2019-2027 (USD Billion)
34 France: Cell & Gene Therapy Raw Material Testing Market, By Type Scope, 2019-2027 (USD Billion)
35 Italy: Cell & Gene Therapy Raw Material Testing Market, By Service Scope, 2019-2027 (USD Billion)
36 Italy: Cell & Gene Therapy Raw Material Testing Market, By Type Scope, 2019-2027 (USD Billion)
37 Spain: Cell & Gene Therapy Raw Material Testing Market, By Service Scope, 2019-2027 (USD Billion)
38 Spain: Cell & Gene Therapy Raw Material Testing Market, By Type Scope, 2019-2027 (USD Billion)
39 Rest Of Europe: Cell & Gene Therapy Raw Material Testing Market, By Service Scope, 2019-2027 (USD Billion)
40 Rest Of Europe: Cell & Gene Therapy Raw Material Testing Market, By Type Scope, 2019-2027 (USD Billion)
41 Asia Pacific: Cell & Gene Therapy Raw Material Testing Market, By Service Scope, 2019-2027 (USD Billion)
42 Asia Pacific: Cell & Gene Therapy Raw Material Testing Market, By Type Scope, 2019-2027 (USD Billion)
43 Asia Pacific: Cell & Gene Therapy Raw Material Testing Market, By Country, 2019-2027 (USD Billion)
44 China: Cell & Gene Therapy Raw Material Testing Market, By Service Scope, 2019-2027 (USD Billion)
45 China: Cell & Gene Therapy Raw Material Testing Market, By Type Scope, 2019-2027 (USD Billion)
46 India: Cell & Gene Therapy Raw Material Testing Market, By Service Scope, 2019-2027 (USD Billion)
47 India: Cell & Gene Therapy Raw Material Testing Market, By Type Scope, 2019-2027 (USD Billion)
48 Japan: Cell & Gene Therapy Raw Material Testing Market, By Service Scope, 2019-2027 (USD Billion)
49 Japan: Cell & Gene Therapy Raw Material Testing Market, By Type Scope, 2019-2027 (USD Billion)
50 South Korea: Cell & Gene Therapy Raw Material Testing Market, By Service Scope, 2019-2027 (USD Billion)
51 South Korea: Cell & Gene Therapy Raw Material Testing Market, By Type Scope, 2019-2027 (USD Billion)
52 Middle East & Africa: Cell & Gene Therapy Raw Material Testing Market, By Service Scope, 2019-2027 (USD Billion)
53 Middle East & Africa: Cell & Gene Therapy Raw Material Testing Market, By Type Scope, 2019-2027 (USD Billion)
54 Middle East & Africa: Cell & Gene Therapy Raw Material Testing Market, By Country, 2019-2027 (USD Billion)
55 Saudi Arabia: Cell & Gene Therapy Raw Material Testing Market, By Service Scope, 2019-2027 (USD Billion)
56 Saudi Arabia: Cell & Gene Therapy Raw Material Testing Market, By Type Scope, 2019-2027 (USD Billion)
57 UAE: Cell & Gene Therapy Raw Material Testing Market, By Service Scope, 2019-2027 (USD Billion)
58 UAE: Cell & Gene Therapy Raw Material Testing Market, By Type Scope, 2019-2027 (USD Billion)
59 Central & South America: Cell & Gene Therapy Raw Material Testing Market, By Service Scope, 2019-2027 (USD Billion)
60 Central & South America: Cell & Gene Therapy Raw Material Testing Market, By Type Scope, 2019-2027 (USD Billion)
61 Central & South America: Cell & Gene Therapy Raw Material Testing Market, By Country, 2019-2027 (USD Billion)
62 Brazil: Cell & Gene Therapy Raw Material Testing Market, By Service Scope, 2019-2027 (USD Billion)
63 Brazil: Cell & Gene Therapy Raw Material Testing Market, By Type Scope, 2019-2027 (USD Billion)
64 Thermo Fisher Scientific: Products Offered
65 Merck KGaA: Products Offered
66 Catalent Inc.: Products Offered
67 Charles River: Products Offered
68 Pace Analytical Life Sciences: Products Offered
69 Agilent Technologies: Products Offered
70 Eurofins Scientific: Products Offered
71 Intertek Group: Products Offered
72 Element Material Technology: Products Offered
73 Other Companies: Products Offered
The Global Cell & Gene Therapy Raw Material Testing Market has been studied from the year 2019 till 2027. However, the CAGR provided in the report is from the year 2022 to 2027. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Cell & Gene Therapy Raw Material Testing Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
